Does CAPMATINIB Cause Hepatotoxicity? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Hepatotoxicity have been filed in association with CAPMATINIB (TABRECTA). This represents 1.0% of all adverse event reports for CAPMATINIB.
22
Reports of Hepatotoxicity with CAPMATINIB
1.0%
of all CAPMATINIB reports
2
Deaths
2
Hospitalizations
How Dangerous Is Hepatotoxicity From CAPMATINIB?
Of the 22 reports, 2 (9.1%) resulted in death, 2 (9.1%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Hepatotoxicity Listed in the Official Label?
Yes, Hepatotoxicity is listed as a known adverse reaction in the official FDA drug label for CAPMATINIB.
What Other Side Effects Does CAPMATINIB Cause?
Death (411)
Peripheral swelling (283)
Fatigue (257)
Oedema peripheral (247)
Nausea (240)
Malignant neoplasm progression (178)
Dyspnoea (141)
Oedema (130)
Asthenia (113)
Non-small cell lung cancer (96)
What Other Drugs Cause Hepatotoxicity?
METHOTREXATE (1,917)
ACETAMINOPHEN (1,557)
LEFLUNOMIDE (829)
HYDROXYCHLOROQUINE (715)
PREDNISONE (707)
RITUXIMAB (702)
ETANERCEPT (699)
ADALIMUMAB (674)
CYCLOPHOSPHAMIDE (632)
SULFASALAZINE (613)
Which CAPMATINIB Alternatives Have Lower Hepatotoxicity Risk?
CAPMATINIB vs CAPREOMYCIN
CAPMATINIB vs CAPSAICIN
CAPMATINIB vs CAPTOPRIL
CAPMATINIB vs CARBAMAZEPINE
CAPMATINIB vs CARBETOCIN